Vivian H. Liu - 08 Feb 2023 Form 4 Insider Report for AYTU BIOPHARMA, INC (AYTU)

Role
Director
Signature
/s/ Joshua Disbrow as attorney-in-fact for Vivian H. Liu
Issuer symbol
AYTU
Transactions as of
08 Feb 2023
Net transactions value
$0
Form type
4
Filing time
10 Feb 2023, 17:13:33 UTC
Previous filing
01 Jul 2022
Next filing
08 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AYTU Common Shares Award $0 +6,500 +2000% $0.000000 6,825 08 Feb 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted share grant. One-third of the restricted shares shall vest on July 1, 2023; the remaining restricted shares shall vest quarterly thereafter, at 1/8th of the remaining grant, with full vesting on July 1, 2025.
F2 Total reflects 1-to-20 reverse stock split effected by the Issuer on January 6, 2023.